Iridex (IRIX) Return on Invested Capital (2021 - 2022)

Iridex's (IRIX) quarterly Return on Invested Capital came in at 0.02% in Q1 2022, down 38.96% quarter-over-quarter from 0.02% in Q4 2021.

Iridex (IRIX) Return on Invested Capital (2021 - 2022) Analysis & Trends

Iridex's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.02% for Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.01%
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.01%
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.01%
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.00%
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.00%
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Iridex	15.93 Mn	11.33 Mn	4.74 Mn	-

Download Data